Abstract
The article contains an analysis of the results of prevention of venous thrombembolism (up to 35 days) in patients with fractures of their femoral and tibial bones, who were subjected to osteosynthesis. Two groups of patients were compared: the 1st was recommended to take Clexane, the 2nd one took Rivaroxaban (Xarelto(R)). In outpatient conditions, the prevention of venous thrombembolism lasted in 12.5 % of patients from the 1st group, and in 70.8 % from the 2nd one.
Highlights
The article contains an analysis of the results of prevention of venous thrombembolism in patients with fractures of their femoral and tibial bones, who were subjected to osteosynthesis
The prevention of venous thrombembolism lasted in 12.5% of patients from the 1st group, and in 70.8% from the 2nd one
Во второй группе профилактику проводили с применением ривароксабана («Ксарелто®») per os в дозе 10 мг, 1 раз в сутки с момента поступления больного в стационар
Summary
The article contains an analysis of the results of prevention of venous thrombembolism (up to 35 days) in patients with fractures of their femoral and tibial bones, who were subjected to osteosynthesis. У 1-й групі в амбулаторних умовах профілактика венозних тромбоемболій тривала у 12,5% пацієнтів, у 2-й групі — у 70,8%. Ключевые слова: ривароксабан, переломы бедренной кости, переломы костей голени, тромбоз глубоких вен, тромбоэмболия легочной артерии
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
